Aquestive Therapeutics, Inc. (AQST) vs OrthoPediatrics Corp. (KIDS)
A side-by-side comparison of Aquestive Therapeutics, Inc. and OrthoPediatrics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.49HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
KIDS
OrthoPediatrics Corp.
$22.70HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — AQST vs KIDS
growth of $100 · dividends reinvested · last 8yAQST -71.5% (-14.5%/yr)KIDS -16.9% (-2.3%/yr)KIDS compounded faster over this window
AQST KIDS
AQST vs KIDS: by the numbers
- •KIDS is the larger company ($583M vs $563M market cap).
- •Both run net losses; KIDS's is the smaller (-15.72% vs -144.63% net margin).
- •KIDS grew revenue faster over the past five years (23.14% vs -0.58% CAGR).
Metrics side by side
Valuation
| Metric | AQST | KIDS |
|---|---|---|
| P/S ratio | 10.42 | 2.31 |
| P/B ratio | N/A | 1.70 |
Profitability
| Metric | AQST | KIDS |
|---|---|---|
| Gross margin | 67.04% | 73.65% |
| Operating margin | -156.36% | -9.01% |
| Net margin | -144.63% | -15.72% |
| ROE | N/A | -11.56% |
| ROIC | -45.62% | -4.97% |
Growth (annualized)
| Metric | AQST | KIDS |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | 23.14% |
| Total return CAGR (5Y) | 2.24% | -18.40% |
Frequently asked
- Which has grown faster, AQST or KIDS?
- Over the past five years, KIDS grew revenue faster — AQST at a -0.58% CAGR versus KIDS at 23.14%.
- How have AQST and KIDS total returns compared?
- Over the past 5 years, AQST delivered 2.24% and KIDS delivered -18.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aquestive Therapeutics ROEOrthoPediatrics ROEAquestive Therapeutics operating marginOrthoPediatrics operating marginAquestive Therapeutics revenue growthOrthoPediatrics revenue growthAquestive Therapeutics free cash flowOrthoPediatrics free cash flow
Aquestive Therapeutics & OrthoPediatrics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.